Skip to main content
TipRanks
Go Ultimate75% OFF

First Tracks Biotherapeutics Inc (TRAX) Stock Statistics & Valuation Metrics

57 Followers

Total Valuation

First Tracks Biotherapeutics Inc has a market cap or net worth of $1.87B. The enterprise value is $1.12B.

Market Cap
$1.87B
Enterprise Value
$1.12B

Share Statistics

First Tracks Biotherapeutics Inc has 42,017,902 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
42,017,902
Owned by Insiders
0.28%
Owned by Institutions
72.01%

Financial Efficiency

First Tracks Biotherapeutics Inc’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -59.35%.

Return on Equity (ROE)
-0.58
Return on Assets (ROA)
-0.50
Return on Invested Capital (ROIC)
-59.35%
Return on Capital Employed (ROCE)
-0.60
Revenue Per Employee
0
Profits Per Employee
-1.60M
Employee Count
104
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of First Tracks Biotherapeutics Inc is -9.91. First Tracks Biotherapeutics Inc’s PEG ratio is 0.11.

PE Ratio
-9.91
PS Ratio
0.00
PB Ratio
10.53
Price to FCF
-15.55
Price to Operating Cash Flow
-13.24
PEG Ratio
0.11

Income Statement

In the last 12 months, First Tracks Biotherapeutics Inc had revenue of 0 and earned -166.09M in profits. Earnings per share was 0.00.

Revenue
0
Gross Profit
-139.61M
Operating Income
-179.01M
Pretax Income
-166.09M
Net Income
-166.09M
EBITDA
-176.58M
Earnings Per Share (EPS)
0.00

Cash Flow

In the last 12 months, operating cash flow was -81.53M and capital expenditures -42,000, giving a free cash flow of -81.57M billion.

Operating Cash Flow
-81.53M
Free Cash Flow
-81.57M
Free Cash Flow per Share
-3.36

Dividends & Yields

First Tracks Biotherapeutics Inc pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-6.43%
Earnings Yield
-9.91%

Stock Price Statistics

Beta
0.48
52-Week Price Change
134.21%
50-Day Moving Average
40.02
200-Day Moving Average
31.72
Relative Strength Index (RSI)
50.22
Average Volume (3m)
827.79K

Important Dates

First Tracks Biotherapeutics Inc upcoming earnings date is ―, After Close (Confirmed).

Last Earnings Date
Nov 03, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

First Tracks Biotherapeutics Inc as a current ratio of 10.20, with Debt / Equity ratio of 4.91%

Current Ratio
10.20
Quick Ratio
10.20
Debt to Market Cap
0.00
Net Debt to EBITDA
1.27
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, First Tracks Biotherapeutics Inc has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

First Tracks Biotherapeutics Inc EV to EBITDA ratio is -10.44, with an EV/FCF ratio of -14.29.

EV to Sales
0.00
EV to EBITDA
-10.44
EV to Free Cash Flow
-14.29
EV to Operating Cash Flow
-14.30

Balance Sheet

First Tracks Biotherapeutics Inc has $155.63M in cash and marketable securities with $3.77M in debt, giving a net cash position of $151.85M billion.

Cash & Marketable Securities
$155.63M
Total Debt
$3.77M
Net Cash
$151.85M
Net Cash Per Share
$3.61
Tangible Book Value Per Share
$4.22

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for First Tracks Biotherapeutics Inc is $75.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$75.40
Price Target Upside
69.44% Upside
Analyst Consensus
Strong Buy
Analyst Count
10
Revenue Growth Forecast
―
EPS Growth Forecast
―

Scores

Smart Score
9
AI Score
49